Combining the cancer vaccine DPX-Survivac with immune modulators.
Eva M
EM
Riedmann
D019496:Cancer Vaccines / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004359:Drug Therapy, Combination; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D009369:Neoplasms / Q000628:therapy*
D019496:Cancer Vaccines; D007155:Immunologic Factors